» Articles » PMID: 33767375

Tackling Healthcare Access Barriers for Individuals with Autism from Diagnosis to Adulthood

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 2021 Mar 26
PMID 33767375
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Most individuals with autism spectrum disorder (ASD)-a complex, life-long developmental disorder-do not have access to the care required to address their diverse health needs. Here, we review: (1) common barriers to healthcare access (shortage/cost of services; physician awareness; stigma); (2) barriers encountered primarily during childhood (limited screening/diagnosis; unclear referral pathways), transition to adulthood (insufficient healthcare transition services; suboptimal physician awareness of healthcare needs) and adulthood (shortage of services/limited insurance; communication difficulties with physicians; limited awareness of healthcare needs of aging adults); and (3) advances in research/program development for better healthcare access. A robust understanding of barriers to accessing healthcare across the lifespan of autistic individuals is critical to ensuring the best use of healthcare resources to improve social, physical, and mental health outcomes. Stakeholders must strengthen healthcare service provision by coming together to: better understand healthcare needs of underserved populations; strengthen medical training on care of autistic individuals; increase public awareness of ASD; promote research into/uptake of tools for ASD screening, diagnosis, and treatment; understand specific healthcare needs of autistic individuals in lower resource countries; and conduct longitudinal studies to understand the lifetime health, social, and economic impacts of ASD and enable the evaluation of novel approaches to increasing healthcare access. IMPACT: Despite the growing body of evidence, our understanding of barriers to healthcare encountered by individuals with ASD remains limited, particularly beyond childhood and in lower resource countries. We describe current and emerging barriers to healthcare access encountered by individuals with ASD across the lifespan. We recommend that stakeholders develop evidence-informed policies, programs, and technologies that address barriers to healthcare access for individuals with ASD and consider broad, equitable implementation to maximize impact.

Citing Articles

Dialectical Behavior Therapy in Autism.

Weiner L, Bemmouna D, Costache M, Martz E Curr Psychiatry Rep. 2025; .

PMID: 40048080 DOI: 10.1007/s11920-025-01596-7.


Canadian developmental pediatrics workforce survey.

McLeod S, Eliason S, Penner M, Mickelson E, Marello A, Fehlings D Paediatr Child Health. 2025; 29(8):501-506.

PMID: 39990035 PMC: 11840247. DOI: 10.1093/pch/pxae012.


Effectiveness of the mobile Stress Autism Mate Junior application in reducing stress and improving quality of life in adolescents with autism: a pilot study.

van Asselt A, Hoeberichts K, Demirel S, Scheeren A, Roke Y Front Psychiatry. 2025; 15():1469257.

PMID: 39845363 PMC: 11750817. DOI: 10.3389/fpsyt.2024.1469257.


A Demographic Description of Children and Adolescents With Concomitant Autism and Anxiety Along With a Comparison of Receipt of Psychological Services.

Salt E, Wiggins A, Toupin D, Parks E, Okoli C, Rayens M J Dev Behav Pediatr. 2025; 46(1):e33-e39.

PMID: 39787493 PMC: 11832331. DOI: 10.1097/DBP.0000000000001321.


Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms.

Manter M, Birtwell K, Bath J, Friedman N, Keary C, Neumeyer A BMC Med. 2025; 23(1):11.

PMID: 39773705 PMC: 11705908. DOI: 10.1186/s12916-024-03814-0.


References
1.
Elsabbagh M, Divan G, Koh Y, Kim Y, Kauchali S, Marcin C . Global prevalence of autism and other pervasive developmental disorders. Autism Res. 2012; 5(3):160-79. PMC: 3763210. DOI: 10.1002/aur.239. View

2.
Buescher A, Cidav Z, Knapp M, Mandell D . Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr. 2014; 168(8):721-8. DOI: 10.1001/jamapediatrics.2014.210. View

3.
Knapp M, Romeo R, Beecham J . Economic cost of autism in the UK. Autism. 2009; 13(3):317-36. DOI: 10.1177/1362361309104246. View

4.
Markowitz L, Reyes C, Embacher R, Speer L, Roizen N, Frazier T . Development and psychometric evaluation of a psychosocial quality-of-life questionnaire for individuals with autism and related developmental disorders. Autism. 2015; 20(7):832-44. PMC: 6296263. DOI: 10.1177/1362361315611382. View

5.
Brookman-Frazee L, Stadnick N, Chlebowski C, Baker-Ericzen M, Ganger W . Characterizing psychiatric comorbidity in children with autism spectrum disorder receiving publicly funded mental health services. Autism. 2017; 22(8):938-952. PMC: 6491206. DOI: 10.1177/1362361317712650. View